U.S. market Open. Closes in 7 minutes

ZOM | Zomedica Corp. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312016-02-292015-02-282014-02-28
Revenue25.19M18.93M4.13MN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue7.87M5.28M1.08M530.02K787.61KN/AN/AN/AN/AN/AN/A
Gross Profit17.32M13.65M3.05M-530.02K-787.61KN/AN/AN/AN/AN/AN/A
Operating Expenses48.91M35.58M24.43M16.76M19.78M16.58MN/A6.00M54.51KN/AN/A
Selling, General & Admin43.17M33.00M22.75M8.19M8.65M6.06MN/A4.43M54.51K42.41K77.50K
Research & Development5.74M2.58M1.67M8.04M10.35M10.32M2.75M1.52MN/AN/AN/A
Other Operating Expenses2.08M-7.00K6.00K530.02K787.61K205.77KN/A45.82KN/AN/AN/A
Operating Income-31.59M-21.92M-21.37M-16.76M-19.78M-16.58M-8.08M-6.00M-54.51K-42.41K-77.50K
Other Expenses / Income-4.27M2.54M657.77K-146.81K273.00-68.44K18.98K-14.30KN/AN/AN/A
Before Tax Income-35.86M-19.38M-20.72M-16.91M-19.78M-16.65M-8.07M-6.01M-54.51K-42.41K-77.50K
Income Tax Expenses-1.33M-2.37M-2.33M9.33K38.08K136.88KN/AN/AN/AN/AN/A
Net Income-34.53M-17.02M-18.38M-16.92M-19.82M-16.65M-8.07M-6.01M-54.51K-42.41K-77.50K
Interest Expenses175.00K1.00K6.05K732.0018.34KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding979.95M979.92M956.53M364.44M106.30M92.49M87.40M80.16M2.50M2.50M842.47K
Diluted Shares Outstanding979.95M979.92M956.53M364.44M106.30M93.44M87.40M80.16M2.50M2.50M842.47K
EBITDA-25.29M-15.19M-19.83M-16.19M-18.98M-16.31M-7.97M-5.94M-54.51K-42.41K-77.50K
EBITDA Margin-100.43%-80.23%-479.66%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-35.69M-19.38M-20.71M-16.91M-19.77M-16.51M-8.07M-6.01M-54.51K-42.41K-77.50K
EBIT Margin-141.69%-102.38%-501.08%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312016-02-292015-02-282014-02-28
An error has occurred. This application may no longer respond until reloaded. Reload 🗙